Welcome to our dedicated page for Streamline Health Solutions In SEC filings (Ticker: STRM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Streamline Health Solutions, Inc. filings document its completed transition from a Nasdaq-listed public company to a wholly owned subsidiary of Mist Holding Co. The record includes Form 8-K disclosures on merger completion, shareholder voting results, material agreements, debt covenant modifications and executive compensation arrangements tied to corporate transactions.
Its Form 25 and Form 15 filings document removal of Streamline Health common stock from Nasdaq listing and registration and certification of termination or suspension of Exchange Act reporting duties. The filing themes center on common stock, shareholder approvals, loan and security agreement amendments, governance, compensation arrangements and public-company status.
Streamline Health Solutions, Inc. submitted a Form 25 notifying removal of its common stock from listing and/or registration on the Nasdaq Stock Market LLC. The filing lists the issuer's principal office and telephone number, cites Nasdaq's statement that it complied with applicable rules to file Form 25, and is signed by Jennifer Fainer, CDO Analyst, dated 2025-08-12.
Streamline Health Solutions, Inc. (Nasdaq: STRM) has mailed a Definitive Proxy Statement (DEFM14A) asking shareholders to approve its all-cash acquisition by Mist Holding Co./MDaudit for $5.34 per share. The Special Meeting will be held virtually on 7 August 2025. If completed, Merger Sub will merge into Streamline, turning the company into a wholly-owned subsidiary of MDaudit, after which STRM shares will be delisted and deregistered.
Financial terms: Holders receive $5.34 in cash for each share—representing a 138% premium to the 28 May 2025 close and a 117% premium to the 30-day VWAP. All restricted shares and in-the-money options/warrants convert to cash on the same economic basis; out-of-the-money options and warrants are cancelled for no consideration. The buyer has certified it possesses sufficient cash, and the deal is not subject to a financing condition.
Approvals & key hurdles: • Merger Proposal requires an unusually high two-thirds (66 ⅔ %) of outstanding STRM shares. • Compensation and Adjournment Proposals require a simple majority of votes cast. • 21.82% of shares are already locked up via Voting Agreements with officers/directors. • Outside closing date is 31 Dec 2025; parties target 3Q-2025 completion. • Standard closing conditions apply, including no injunctions and accuracy of reps & warranties.
Governance & deal protections: • Streamline has a customary “no-shop” clause with fiduciary-out and five-business-day match right. • A termination fee of $950,000 (≈2.3% of equity value) is payable under specified circumstances, including a superior proposal. • Appraisal rights are available to shareholders who strictly follow DGCL §262 procedures.
Strategic rationale highlighted by the Board: Cain Brothers opined that the consideration is fair from a financial perspective. Directors cite immediate liquidity at a substantial premium, certainty of value, and lack of financing risk. The Board unanimously recommends voting “FOR” all three proposals.
Implications for investors: Shareholders gain immediate cash at a triple-digit premium but forgo future upside and lose public equity liquidity. Failure to achieve the two-thirds threshold or satisfy closing conditions would leave STRM independent, potentially causing the share price to revert toward pre-announcement levels. Active voting is critical because non-votes count as “AGAINST” the Merger Proposal.